Methods and Findings in Experimental
and Clinical Pharmacology
Vol. 24, Suppl. A, 2002, pp. 175-177
ISSN 0379-0355
Copyright 2002 Prous Science, S.A.
CCC: 0379-0355/2002
http://www.prous.com
General Index
A | B | C | D | E | F | G | H | I | K | L | M | N | O | P | Q | R | S | T | U | V | W
|
A
Acetylcholine, 96 Acetylsalicyclic acid, 149 Acute hypoxia, 95 Adrenaline release, 92 a1-Adrenoceptor antagonists, 99, 102, 104, 158 a1-Adrenoceptor vasoconstriction, 102 a1D-Adrenoceptors, 72 a2-Adrenoceptors, 153 b-Adrenoceptor mediated relaxation, 101 Agmatine, 109 Almotriptan, 33 Alzheimer's disease, 151 AMPA receptor, 154 Angiotensin converting enzyme, 105 Angiotensin II, 74, 91, 92 Antidepressants, 154, 155, 156 Anti-Fas antibody apoptosis, 80 Antinociception, 111 Antioxidants, 132 Antiplatelet therapy, 106 Apoptosis, 81, 83, 145, 146, 147 Argan oil, 104 Aromatic amino acids, 135 Astrocytes, 81, 83 Atherosclerosis, 74 |
B
Baccharis pentlandii, 137 Baccharis spp., 139 Baccharis subalata, 138 Benign prostatic hypertrophy, 158 Benzodiazepines, 163 Benzylisouinolines, 162 Bone cancer pain, 112 Brain-derived neurotrophic factor, 155 Bupivacaine, 70 |
C
Cannabinoids, 82 Cannabinoid CB1 receptor antagonists, 155 Canrenone, 69 Celecoxib, 106 Cell proliferation, 81 Chemoprevention, 97 Chemotherapy-induced nausea and vomiting, 117 Chloride channels, 103 Cholecystokinin, 79, 157 Choline, 163 Chondroitin sulfate, 35 Chronic gastric lesions, 129 Chronic liver disease, 76 Chronic obstructive pulmonary disease, 5 Chronic pain, 156 Chronic venous insufficiency, 100 Clopidogrel, 107, 114 Clozapine, 165 Colitis, 140, 141 Colonic adenocarcinoma, 97 Colonic damage, 108, 129 w-conotoxin GVIA, 97 Continuing education, 121, 122 Core curricula, 19, 21, 23, 25, 27, 29 CSP-2503, 167 Cyclin-dependent kinases inhibitors, 83 Cyclooxygenase-1, 77, 106, 129 Cyclooxygenase-2, 71, 77, 129, 101, 108 Cyclosporin A, 147 Cytosolic Ca+2, 108 |
|
D
Desipramine, 154 Diabetes, 78, 93, 98, 107, 116, 118 Diabetic vasculopathy, 61 Dietetic supplementation, 107, 134 Digitalis purpurea spp. heywoodii, 141 5,7-dihydroxyflavone, 89 Diomectite, 136 Diosmin flavonoids, 135 Dopamine glycosyl derivatives, 146 |
E
Endothelial factors, 102 Endothelial function, 90 Endothelin-1, 98 Endotoxin, 95, 113 Eosinophils, 75 Erectile function, 96 Escherichia coli, 94 Ethanol, 139 Evolus, 105 |
F
F-98212-TA, 82 Flavonoids, 59 Focal cerebral ischemia, 47 |
|
G
Gadd153, 83 Galantamine, 151 Ga-subunits, 81 Gastric acid secretion, 73 Gastric inflammation, 130 Gastric mucosal damage, 95 Gastrin, 128 Gene therapy, 3 Gene transport, 123 Generic drugs, 105 Genistein, 91 Glucose, 78, 98 Glycemia, 131 G-proteins, 109, 166 Growth arrest specific gene 1-induced death, 43 |
H
Haloperidol, 165 Heat shock treatment, 145 Helicobacter pylori, 94 Heroin addiction, 161 HIV, 138, 139 HL-60 cells, 145 5-HT, 92 5-HT1A, 94, 152, 167 5-HT1B, 166 5-HT2A, 165, 166 5-HT3, 167 5-Hydroxy-propafenone, 87 6-Hydroxydopamine-induced cell death, 150 Hormone replacement therapy, 119 Human cardiac potassium currents, 88 (±)Huprine X, 148 Hyperglycemia, 78 Hypericum perforatum, 55 Hypertension, 13, 70, 71, 72, 90, 96, 100, 104, 105 Hypotension, 91 |
I
Idiosyncratic liver disease, 130 I2 Imidazoline receptor ligands, 160 I2 Imidazoline receptors, 153 Imipramine, 152 Inducible nitric oxide synthase, 71, 101 Insulin release, 157 Insulin secretion, 131 Intraocular pressure, 97 Irbesartan, 88 Iridoids, 140 Ispaghula husk, 75 |
|
K
Knowledge database, 116 Kv Channels, 88 Kvb1.3, 70 |
L
Lanreotide, 119 Leptin, 132 Lerisetron, 117, 118 Levamisole, 117 Levodopa, 75 Lipolysis, 131 Lipopolyplex vectors, 123, 144 Lipopolysaccaride, 70 Liver disease, 3
L-NAME, 97
|
M
Melatonin, 145 Methadone, 110 Mineral waters, 128 Monofunctional inducers, 142 Molecular manipulation, 9 Morphine, 109, 111 Morphine tolerance, 74, 121, 152 MUC5AC expression, 136 Muscarinic receptor agonists, 158 |
|
N
NA synthesis, 161 N-acetylcysteine, 39, 135 Nefazodone, 162 Neurodegenerative disease, 147 Neuroprotection, 47, 148, 149 Neutrophil accumulation, 92 Nicotine-mediated responses, 163 Nitric oxide, 78, 79, 80, 89, 92, 93, 95, 98, 113, 114 7-Nitroindazol, 121 Nitroglycerin, 103 nNOS expression, 94 Noradrenaline, 153 Noradrenergic and nitroxydergic responses, 159 |
O
m opioid receptors, 92 m-Opioid receptor agonists, 110 Osteoarthritis, 35 [3H]Oubain, 74 Over the counter drugs, 124 Oxidative stress, 107, 132, 133 Oxygen free radicals, 133 |
P
Pain, 162 Paracetamol, 164 Parkinson's disease, 75 PDE4 inhibition, 136, 146 Penile resistance arteries, 65, 71 Peripheral occlusive arteriopathy, 103 Pharmacovigilance, 120 Phlebotonic drugs, 100 PhLPlong protein, 152 Phosphodiesterase 1 and 5, 89 Phosphoinositide hydrolysis, 102 Physiotherapy, 123 Phytoestrogens, 51, 90, 99 Phytosoya®, 53 Plantago ovata, 141 Platelet function, 106, 140 Practical activities in pharmacology, 122 Prazosin, 72 Presynaptic a2 autoreceptors, 161 Primary care management, 76 Pro-apoptotic FAS receptor proteins, 161 Progesterone formulations, 115 Propafenone, 87 Propofol, 116, 118 Protein kinase inhibitors, 75 Psychiatric disorders, 122 Pulmonary artery vasodilation, 108 Pulmonary vasoconstriction, 88 |
|
Q
Quercetin, 90, 100, 135, 140 |
R
s1 Receptors, 157 s1 Receptor antagonists, 111 Red wine, 139 Reserpine, 161 Retinal ischemia, 78 Rofecoxib, 106, 108, 129 Rupatadine, 37 |
S
S-adenosylmethionone, 127 Salicylic acid, 148, 149 Scolymus hispanicus L., 143 Scrophularia scorodonia L., 142, 143 Seaweed supplementation, 133 Serotonergic vasoconstriction, 92 S-nitro-N-acetyl-penicillamine, 79 SNX-482, 164 Social pharmacology, 124, 125 Somatostatin, 73 Spinal analgesia, 109 Spironolactone, 69 Stephenanthrine, 91 Sufentanil, 150 |
|
T
Tacrine-huperzine A hybrids, 147 Terazosin, 96 TGF-b, 159 Thermal hyperalgesia, 112 Thromboxane A2, 88 Thymus pipirella L. extracts, 137 TNF-a, 98 Tramadol, 156 Trifusal, 149 Tuberaria lignosa, 138 |
U
Ultraviolet radiation, 134 Uvariopsine, 91 |
V
Vascular aging, 63 Vascular tone, 79 Vasoactive agents, 71 Venlafaxine, 156 Veratridine-induced chromaffin cell death, 45 Vitamin E, 135 |
|
W
WAY-100635, 156 White wine, 139 |
||
Methods and Findings in Experimental and
Clinical Pharmacology Vol. 24, Suppl. A, 2002, pp. 175-177
ISSN 0379-0355 Copyright 2002 Prous Science, S.A. CCC: 0379-0355/2002 http://www.prous.com